Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in hypoxia in three-dimensional in vitro model.

2015/17/N/NZ5/00691

Keywords:

drug resistance anti-angiogenic therapy renal cell carcinoma 3D cell cultures tyrosine kinase inhibitors stem-like cells

Descriptors:

  • NZ5_1: Etiology of human diseases
  • NZ1_9: Biotechnology
  • NZ2_3: Proteomics

Panel:

NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution :

Wojskowy Instytut Medyczny

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

Zofia Bielecka 

Number of co-investigators in the project: 2

Call: PRELUDIUM 9 - announced on 2015-03-16

Amount awarded: 149 040 PLN

Project start date (Y-m-d): 2016-01-26

Project end date (Y-m-d): 2019-01-25

Project duration:: 36 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (1)
  • Articles in post-conference publications (4)
  1. Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells.
    Authors:
    Bielecka ZF, Malinowska A, Brodaczewska KK, Klemba A, Kieda C, Krasowski P, Grzesiuk E, Piwowarski J, Czarnecka AM, Szczylik C.
    Academic press:
    Cell & Bioscience (rok: 2017, tom: 0,340972222222222, strony: eCollection 2017), Wydawca: BMC
    Status:
    Published
    DOI:
    10.1186/s13578-017-0197-8 - link to the publication
  1. Laminin and poly-D-lysine pre-coating enable effective drug testing in renal cell carcinoma
    Authors:
    Z.F.Bielecka, K.K.Brodaczewska, K.Maliszewska-Olejniczak, C.Szczylik, A.M.Czarnecka
    Conference:
    32nd Ernst Klenk Symposium in Molecular Medicine (rok: 2016, ), Wydawca: Centre for Molecular Medicine Cologne
    Data:
    konferencja 8-10/12/2016
    Status:
    Published
  2. Parametry hodowli trójwymiarowych a reakcja komórek raka nerki na inhibitory kinaz tyrozynowych (TKI) i inhibitory kinazy mTOR/cytostatyki.
    Authors:
    Z.F. Bielecka, K.K. Brodaczewska, C. Szczylik, A.M. Czarnecka
    Conference:
    IV Kongres Onkologii Polskiej (rok: 2016, ), Wydawca: NOWOTWORY. Journal of Oncology.
    Data:
    konferencja 12-15.10.2016, Łódź, Polska
    Status:
    Published
  3. Lekooporność na inhibitory kinaz tyrozynowych w modelach dwu- i trójwymiarowych in vitro raka nerkowokomórkowego.
    Authors:
    Z.F. Bielecka, A. Malinowska, P. Krasowski, S. Lewicki, K.K. Brodaczewska, C. Kieda, A.M. Czarnecka, C. Szczylik
    Conference:
    7 Konferencja "Postępy w Badaniach Biomedycznych" (rok: 2016, ), Wydawca: SKN przy Warszawskim Uniwersytecie Medycznym
    Data:
    konferencja 10-11.12.2016, Warszawa, Polska
    Status:
    Published
  4. Protein expression profiling of sorafenib-resistant human renal cancer stem-like cells in three-dimensional in vitro model
    Authors:
    Z. F. Bielecka, A. Malinowska, P. Krasowski, C. Kieda, C. Szczylik
    Conference:
    19th Euro Congress on Cancer Science and Therapy (rok: 2017, ), Wydawca: Cancer Science
    Data:
    konferencja 17-19-07-2017
    Status:
    Published